Cusatuzumab (anti-CD70) is a human αCD70 monoclonal antibody. Cusatuzumab (anti-CD70) shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab (anti-CD70) reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab (anti-CD70) has the potential for the research of Acute myeloid leukemia (AML).Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg.
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/AB170844-SCI_2404238019a9dd313d73c1f5f8733892.pdf
- UPC:
- 51111717
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab170844-1mg
- CAS:
- 1864871-20-4
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





